🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/03/2007 37,50 38,70 36,00 36,00 -5,51% 7,20% 10.030
02/03/2007 39,40 39,40 37,30 38,10 -1,75% 5,33% 4.920
01/03/2007 37,10 39,20 37,00 38,78 +2,32% 5,93% 5.260
28/02/2007 38,90 39,50 37,20 37,90 +0,26% 5,91% 5.200
27/02/2007 38,57 38,57 37,00 37,80 -2,07% 4,07% 5.850
26/02/2007 38,20 40,30 38,20 38,60 -1,28% 5,50% 4.950
23/02/2007 40,30 40,30 38,20 39,10 -0,51% 5,21% 2.940
22/02/2007 39,90 40,30 38,80 39,30 -1,95% 3,76% 7.480
21/02/2007 39,80 40,60 39,20 40,08 +0,45% 3,52% 5.230
20/02/2007 39,80 40,60 39,40 39,90 -0,94% 3,02% 3.020
16/02/2007 40,30 40,50 40,00 40,28 -1,03% 1,24% 1.080
15/02/2007 41,20 41,40 39,00 40,70 -1,90% 5,83% 8.610
14/02/2007 39,70 41,80 39,60 41,49 +3,78% 5,54% 5.830
13/02/2007 39,60 40,80 39,60 39,98 -1,72% 3,03% 3.850
12/02/2007 40,45 40,90 40,10 40,68 +0,20% 1,98% 4.030
09/02/2007 40,90 41,00 39,80 40,60 -0,20% 2,93% 2.180
08/02/2007 39,90 41,00 39,50 40,68 +2,06% 3,76% 6.290
07/02/2007 40,00 40,10 39,60 39,86 +0,20% 1,25% 3.130
06/02/2007 38,60 40,20 38,60 39,78 +3,06% 4,15% 3.160
05/02/2007 40,40 40,50 38,10 38,60 -5,14% 5,94% 4.440
02/02/2007 40,30 40,70 40,10 40,69 +0,32% 1,49% 2.330
01/02/2007 41,90 41,90 40,10 40,56 -1,46% 4,30% 3.950
31/01/2007 40,80 41,90 38,80 41,16 +0,24% 7,60% 4.310
30/01/2007 41,00 42,00 39,90 41,06 -0,48% 5,12% 4.560
29/01/2007 39,80 41,40 39,80 41,26 +2,64% 4,02% 3.870
26/01/2007 40,20 40,30 38,40 40,20 +2,81% 4,73% 5.650
25/01/2007 38,00 39,66 36,90 39,10 +2,62% 7,26% 6.560
24/01/2007 38,20 39,00 37,90 38,10 -1,70% 2,88% 7.070
23/01/2007 40,00 40,00 38,50 38,76 -2,27% 3,75% 14.310
22/01/2007 40,40 41,50 39,50 39,66 -2,03% 4,95% 4.200